Page 35 of 44
EN2.11 | Topical Medication Instillation Technique — SDL Guide (Part 2)
Interpreting Correct vs Incorrect Technique and Outcomes
Recognising the consequences of incorrect technique allows the clinician to diagnose technique failure when a patient is not responding to a topical medication as expected. Most apparent 'treatment failures' in topical ENT therapy are technique failures — the medication is correct, but it is not being applied in a way that reaches the target tissue. This diagnostic step — asking not 'has the drug failed?' but 'how is the patient using the drug?' — is a clinical habit that saves unnecessary escalation to systemic antibiotics, steroid courses, and surgical referrals. The following consequences of incorrect technique are each directly traceable to a specific step omitted or performed incorrectly in the technique sections above, and each has a straightforward correction that can be taught in the outpatient clinic in under two minutes. Recognising which step was missed, demonstrating the correct step, and confirming the patient can replicate it before leaving is the complete clinical intervention for technique-related treatment failure.
Consequences of incorrect ear drop technique:
- Not pulling the pinna: drops pool in the curved cartilaginous canal and do not reach the TM. The patient has used the drops correctly (in their view) but the medication never reached the middle ear.
- Sitting upright immediately after instillation: drops drain out of the canal by gravity before they can act. Five to ten minutes in the lateral position is required.
- Cold drops: dizziness and nausea from caloric stimulation → patient stops using the drops after one or two doses.
- Using aminoglycoside drops with a TM perforation: SNHL — irreversible; the most serious technique-related outcome in ear drop use.
Consequences of incorrect nasal spray technique:
- Aiming at the septum: repeated daily spray directly onto the nasal septum causes mucosal atrophy and, over months–years, nasal septal perforation — a serious, difficult-to-repair complication. Crusting and epistaxis from the septum are early warning signs.
- Hyperextending the head: drops or spray falls into the nasopharynx and is swallowed — increasing systemic corticosteroid absorption and reducing local mucosal effect.
- Using decongestant nasal spray for >5 days: Rhinitis medicamentosa (rebound congestion) — the nasal mucosa becomes dependent on the vasoconstrictive effect; stopping the spray causes severe rebound swelling. Withdrawal requires gradual reduction and intranasal steroid support.
Assessment of response to nasal steroid spray:
Intranasal corticosteroids have a delayed onset (1–2 weeks for measurable effect; 4–6 weeks for full effect). Patients who use the spray correctly for <1 week and report 'it's not working' must be counselled on adherence and realistic expectations. A trial of at least 4–6 weeks with correct technique is required before concluding the medication is ineffective.
CLINICAL PEARL
The 'cross-hand technique' for nasal spray instillation is one of the most practically useful tips in ENT outpatient practice. Most patients use the nasal spray with the same hand as the treated nostril — they pick up the bottle in the right hand and spray the right nostril. This angles the nozzle toward the nasal septum (medially). The cross-hand technique — right hand for left nostril, left hand for right nostril — automatically angles the nozzle laterally toward the inferior turbinate where the corticosteroid needs to act. Teaching this technique explicitly at the first prescription takes less than 60 seconds and dramatically improves both safety (no septum contact) and efficacy (spray reaches the correct target tissue).
Applied Practice: Topical Instillation Simulation
The following simulation scenarios are designed to be practised on a model ear and a nasal spray model (or on a partner under supervision) before your skills laboratory OSCE session. For each scenario, perform each step aloud — narrating what you are doing and why builds both self-assessment skill and the communication habit required when instructing patients.
Simulation 1 — Ear drop instillation for CSOM:
Patient: 28-year-old male with CSOM (central perforation confirmed on otoscopy). Prescribed ciprofloxacin 0.3% ear drops, 5 drops to the right ear, twice daily.
Simulation steps: (1) Confirm TM status before instilling — correct drop choice for perforation. (2) Warm the bottle. (3) Lie the patient (or manikin ear) with right ear up. (4) Pull the right pinna upward and backward (demonstrate correct direction). (5) Instil 5 drops at the canal entrance. (6) Perform tragal pumping × 10 compressions. (7) Advise patient to remain lying for 5–10 minutes. Demonstrate patient counselling: 'Warm the drops before use; lie down after putting in the drops; do not use any aminoglycoside drops I might prescribe you in future if you have a perforation.'
Simulation 2 — Nasal steroid spray instruction for allergic rhinitis:
Patient: 22-year-old female with perennial allergic rhinitis. Prescribed mometasone furoate nasal spray, 2 sprays per nostril, once daily.
Simulation steps: (1) Blow the nose first. (2) Hold head slightly forward. (3) Cross-hand technique — demonstrate using left hand for right nostril. (4) Angle nozzle toward the outer corner of the same eye (not the septum). (5) Press pump + gentle sniff. (6) Repeat for the other nostril (right hand for left nostril). Counselling: 'Use every day even when your nose feels clear — the spray works by reducing inflammation over time; it will take 1–2 weeks before you notice the full effect. Do not spray onto the middle of the nose (septum).' Patient question: 'How long do I need to use this?' — 'At least 4–6 weeks to judge the full effect; then continue for the pollen season or year-round for perennial allergy.'
Self-Assessment: Topical Medication Competency Check
Answer these questions to confirm your readiness before the OSCE.
Q1: A patient with otomycosis and an intact TM is prescribed clotrimazole ear drops. What position should the patient be in during instillation, and for how long must they maintain it?
Answer: Patient lies on their side with the treated ear UP. Maintain position for 5–10 minutes after instillation (tragal pumping optional but helpful). The drop is warmed before use to avoid caloric nystagmus.
Q2: A patient has been using oxymetazoline nasal spray for 3 weeks for nasal congestion. She says her nose is 'now worse than ever' when she stops using the spray. What has happened?
Answer: Rhinitis medicamentosa — rebound congestion from prolonged use of topical decongestants (maximum 3–5 days). The nasal mucosa becomes dependent on the vasoconstrictive effect; withdrawal causes severe rebound swelling. Management: gradual withdrawal; intranasal corticosteroid spray to support weaning; explanation to avoid decongestant sprays for more than 5 days in future.
Q3: What is Moffett's position, and for which nasal medication is it used?
Answer: Moffett's position — patient kneels over the edge of a bed with the head lowered so the nose points toward the floor (or lies supine with the head hanging over the table edge). Used for instillation of decongestant drops (e.g. 0.5% or 1% ephedrine drops) to the middle meatus and anterior ethmoid — the position uses gravity to direct drops to the ostiomeatal complex. Also used for Moffett's solution preparation before nasal procedures (cocaine + adrenaline + sodium bicarbonate in the original formula — now replaced by Co-phenylcaine in most settings).
| Medication | Correct patient position | Key safety point |
|---|---|---|
| Ear drops (CSOM, intact TM) | Lying — treated ear up for 5–10 min | Aminoglycosides safe only if TM intact |
| Ear drops (CSOM, perforated TM) | Lying — treated ear up for 5–10 min | Use quinolone only; NO aminoglycosides |
| Nasal steroid spray | Head slightly forward, cross-hand technique | Aim at inferior turbinate, NOT septum |
| Decongestant nasal spray | Head upright | Maximum 3–5 days; rhinitis medicamentosa if prolonged |
| Nasal drops (to middle meatus) | Moffett's position (head down) | Position needed for drops to reach middle meatus |
SELF-CHECK
A patient using a nasal steroid spray complains of intermittent nosebleeds and notices a small crusted area on her nasal septum after 6 months of use. The most likely cause is:
A. Allergic reaction to the spray propellant
B. Incorrect technique — spray aimed at the nasal septum instead of the inferior turbinate, causing mucosal atrophy
C. The spray has run out and she is using an empty bottle
D. Rhinitis medicamentosa from prolonged nasal steroid use
Reveal Answer
Answer: B. Incorrect technique — spray aimed at the nasal septum instead of the inferior turbinate, causing mucosal atrophy
Nasal septal crusting, intermittent epistaxis, and eventual septal perforation are recognised complications of long-term intranasal corticosteroid spray directed at the nasal septum instead of the inferior turbinate. The correct technique is to angle the nozzle toward the lateral nasal wall (inferior turbinate) using the cross-hand technique. Rhinitis medicamentosa is a complication of topical decongestants, not nasal steroids. The cross-hand technique (right hand for left nostril, left hand for right nostril) is the specific technique correction to prevent this complication.